Monopar Therapeutics Inc.: income taxes paid, net
Income taxes paid, net for Monopar Therapeutics Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Monopar Therapeutics Inc. financial histories
What this measure means
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
Exact concept: us-gaap:IncomeTaxesPaidNet. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-01-01 to 2021-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2021-01-01 | 2021-12-31 | 0 | USD | 2022-03-24 | 10-K · 0001654954-22-003701 |
| 2020-01-01 | 2020-12-31 | -11,099 | USD | 2022-03-24 | 10-K · 0001654954-22-003701 |
| 2019-01-01 | 2019-12-31 | 53 | USD | 2021-03-25 | 10-K · 0001654954-21-003243 |
Related financial histories
- Monopar Therapeutics Inc.: total assets
- Monopar Therapeutics Inc.: total liabilities
- Monopar Therapeutics Inc.: stockholders equity
- Monopar Therapeutics Inc.: cash and cash equivalents
- Monopar Therapeutics Inc.: net income or loss
- Monopar Therapeutics Inc.: operating cash flow
- Monopar Therapeutics Inc.: revenue
- Monopar Therapeutics Inc.: financing cash flow
- Monopar Therapeutics Inc.: investing cash flow
- Monopar Therapeutics Inc.: retained earnings or deficit
- Monopar Therapeutics Inc.: basic weighted-average shares
- Monopar Therapeutics Inc.: basic earnings per share
- Monopar Therapeutics Inc.: income tax expense or benefit
- Monopar Therapeutics Inc.: share-based compensation expense
- Monopar Therapeutics Inc.: operating income or loss
- Monopar Therapeutics Inc.: current assets
- Monopar Therapeutics Inc.: current liabilities
- Monopar Therapeutics Inc.: operating expenses
- Monopar Therapeutics Inc.: research and development expense
- Monopar Therapeutics Inc.: common shares outstanding
- Monopar Therapeutics Inc.: cash including restricted cash
- Monopar Therapeutics Inc.: additional paid-in capital
- Monopar Therapeutics Inc.: accumulated other comprehensive income or loss
- Monopar Therapeutics Inc.: operating lease right-of-use asset
- Monopar Therapeutics Inc.: operating lease liability
- Monopar Therapeutics Inc.: other noncurrent assets
- Monopar Therapeutics Inc.: net deferred tax assets
- Monopar Therapeutics Inc.: pre-tax income or loss from continuing operations
- Monopar Therapeutics Inc.: comprehensive income or loss
- Monopar Therapeutics Inc.: general and administrative expense
- Monopar Therapeutics Inc.: current income tax expense or benefit
- Monopar Therapeutics Inc.: deferred income tax expense or benefit
- Monopar Therapeutics Inc.: proceeds from issuing common stock
Inspect the source
- Entity
- Monopar Therapeutics Inc. / CIK 0001645469
- Captured
- 2026-09-21T17:22:36.466Z
- SEC response SHA-256
11b3f240217511123d89b32408ab3beb4dce0c8844d2a4f4fb7c1085084888d1
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001645469.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))